Type
1.
Ozaki M, Kumano K, Nogami R, al, Otsuka A, Horiguchi Y, et al. Basophils Infiltrate the Skin Lesions in Lepromatous Leprosy. Acta dermato-venereologica [Internet]. 2012; Available from: http://www.medicaljournals.se/acta/content/?doi=10.2340/00015555-1329&html=1
Type
1.
Ottenhoff T. New insights and tools to combat leprosy nerve damage. Leprosy review [Internet]. 2011;82(4):334-7. Available from: http://www.lepra.org.uk/platforms/lepra/files/lr/Dec11/1722_Editorial.pdf
Type
1.
Serafín-López, Talavera-Paulin, Amador-Molina, Alvarado-Riverón, Vilchis-Landeros, Méndez-Ortega, et al. Enoyl-coenzyme A hydratase and antigen 85B of Mycobacterium habana are specifically recognized by antibodies in sera from leprosy patients. Clinical and vaccine immunology : CVI [Internet]. 2011;18(7):1097-103. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147323/pdf/zcd1097.pdf
Type
1.
Simeoni S, Puccetti A, Tinazzi E, Codella OM, Sorleto M, Patuzzo G, et al. Leprosy initially misdiagnosed as sarcoidosis, adult-onset still disease, or autoinflammatory disease. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2011;17(8):432-5.
Type
1.
Geluk A, Franken K, Ottenhoff T, Aseffa A, Sapkota BR, Hagge D Anandaban Hospital and Mycobacterial Research Laboratories, The Leprosy Mission Nepal, Kathmandu, Nepal, et al. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa. Leprosy review [Internet]. 2011;82(4):445-58. Available from: http://www.lepra.org.uk/platforms/lepra/files/lr/Dec11/1693.pdf
Type
1.
Parkash O. Serological detection of leprosy employing Mycobacterium leprae derived serine-rich 45 kDa, ESAT-6, CFP-10 and PGL-I: a compilation of data from studies in Indian populations. Leprosy review [Internet]. 2011;82(4):383-8. Available from: http://www.lepra.org.uk/platforms/lepra/files/lr/Dec11/1709.pdf
Type
1.
Zavala-Cerna M, Fafutis-Morris M, Guillen-Vargas C, Salazar-Páramo M, García-Cruz D, Riebeling C, et al. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor sera titers in leprosy patients from Mexico. Rheumatology international. 2012;32(11):3531-6.
Type
1.
Bassukas I, Gaitanis G, Hundeiker M. Leprosy and the natural selection for psoriasis. Medical hypotheses. 2012;78(1):183-90.
Type
1.
Pinquier, groupe d’histopathologie cutanée de Société française de dermatologie. [Histopathology of leprosy]. Annales de dermatologie et de venereologie. 2011;138(11):777-81.
Type
1.
Sampaio, Sousa, Barcelos, Reed, Stefani, Duthie MS. Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2012;31(7):1443-51.
Pagination
- Previous page
- Page 339
- Next page